ERBB3 and intestinal neoplasm: S. flexneri C.11 and its metabolites enhanced the binding of ERBB3 to Nrg1, activating the PI3K-AKT and mTOR pathways, which subsequently promoted the malignant transformation of normal intestinal epithelial cells and progression of intestinal tumors in mice.